Latest & greatest articles for myocardial infarction

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on myocardial infarction or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on myocardial infarction and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for myocardial infarction

1281. Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction. (PubMed)

Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction. The incidence of ventricular arrhythmias after myocardial infarction has been compared in a controlled study of procainamide, mexiletine, and placebo. Sixty male patients who has sustained a myocardial infarction and had received lignocaine for ventricular tachycardia or ventricular ectopic beats which were R-on-T, multiform, or close-coupled took part. The efficacy of the drugs (...) compared with 95% of those receiving mexiletine, both drugs were equally effective antiarrhythmically. The only major adverse effect of therapy noted was development of a positive antinuclear factor in a procainamide-treated patient. These results demonstrate the efficacy of oral antiarrhythmic agents in the management of ventricular arrhythmias after acute myocardial infarction. Mexiletine has the advantage of less frequent administration and lower toxicity.

1975 Lancet

1282. A double-blind trial of patient-controlled nitrous-oxide/oxygen analgesia in myocardial infarction. (PubMed)

A double-blind trial of patient-controlled nitrous-oxide/oxygen analgesia in myocardial infarction. The analgesic effect of self-administered nitrous oxide 50%/oxygen 50% ('Entonox" analgesic apparatus) was compared with air given by the same method in a double-blind trial in 81 patients with myocardial infarction. Self-administered nitrous oxide/oxygen, which was associated with a low frequency of side-effects, proved significantly more effective than air in the early relief of severe cardiac

1975 Lancet

1283. Value of early ambulation in patients with and without complications after acute myocardial infarction. (PubMed)

Value of early ambulation in patients with and without complications after acute myocardial infarction. A prospective, controlled, randomized study was done to compare the effect of early and late ambulation in hospitalized patients with acute myocardial infarction. All patients surviving longer than the first five days were studied; 64 patients were mobilized on day six and discharged on day 12, and 65 were mobilized on day 13 and discharged on day 19. Follow-up observation lasted from six

1975 NEJM

1284. Controlled trial of urokinase in myocardial infarction. A European Collaborative Study. (PubMed)

Controlled trial of urokinase in myocardial infarction. A European Collaborative Study. 341 patients with acute myocardial infarction have been treated in intensive or coronary care units. They were randomised into two groups, 172 receiving urokinase and 169 receiving a glucose infusion. Thereafter they were anticoagulated first with heparin and then for a year with oral anticoagulants. Despite a significantly faster regression of electrocardiographic alterations in the urokinase group

1975 Lancet

1285. Anticoagulants in acute myocardial infarction. Results of a cooperative clinical trial. (PubMed)

Anticoagulants in acute myocardial infarction. Results of a cooperative clinical trial. 4578167 1973 09 21 2016 10 17 0098-7484 225 7 1973 Aug 13 JAMA JAMA Anticoagulants in acute myocardial infarction. Results of a cooperative clinical trial. 724-9 eng Clinical Trial Journal Article Randomized Controlled Trial United States JAMA 7501160 0098-7484 0 Anticoagulants 0 Placebos 5Q7ZVV76EI Warfarin 9005-49-6 Heparin 9NEZ333N27 Sodium AIM IM Acute Disease Adult Aged Anticoagulants adverse effects (...) therapeutic use Arrhythmias, Cardiac diagnosis Clinical Trials as Topic Electrocardiography Female Heart Block diagnosis Heart Failure diagnosis Hemorrhage chemically induced Heparin therapeutic use Humans Male Middle Aged Myocardial Infarction drug therapy mortality Placebos Prothrombin Time Pulmonary Embolism diagnosis Sampling Studies Sodium therapeutic use Thrombosis diagnosis Warfarin therapeutic use 1973 8 13 1973 8 13 0 1 1973 8 13 0 0 ppublish 4578167

1973 JAMA

1286. Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction. (PubMed)

Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction. 4117261 1973 01 05 2016 10 17 0098-7484 222 5 1972 Oct 30 JAMA JAMA Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction. 541-8 Drapkin A A Merskey C C eng Clinical Trial Journal Article Randomized Controlled Trial United States JAMA 7501160 0098-7484 0 Anticoagulants 0 (...) Placebos 5M7Y6274ZE Phenindione 5Q7ZVV76EI Warfarin 7QID3E7BG7 Dicumarol 9005-49-6 Heparin AIM IM Age Factors Aged Anticoagulants adverse effects therapeutic use Cerebrovascular Disorders mortality Clinical Trials as Topic Diabetes Complications Dicumarol therapeutic use Electrocardiography Female Heart Failure complications Hemorrhage chemically induced Heparin therapeutic use Humans Hypertension complications Male Middle Aged Myocardial Infarction complications drug therapy mortality Phenindione

1973 JAMA

1287. Long-term anticoagulant therapy after myocardial infarction. Final report of the Veterans Administration cooperative study. (PubMed)

Long-term anticoagulant therapy after myocardial infarction. Final report of the Veterans Administration cooperative study. 4885975 1969 04 16 2016 10 17 0098-7484 207 12 1969 Mar 24 JAMA JAMA Long-term anticoagulant therapy after myocardial infarction. Final report of the Veterans Administration cooperative study. 2263-7 Ebert R V RV eng Clinical Trial Journal Article Randomized Controlled Trial United States JAMA 7501160 0098-7484 0 Anticoagulants 97C5T2UQ7J Cholesterol AIM IM Anticoagulants (...) administration & dosage Cholesterol blood Clinical Trials as Topic Follow-Up Studies Heart Failure complications Hospitals, Veterans Humans Middle Aged Myocardial Infarction blood drug therapy mortality 1969 3 24 1969 3 24 0 1 1969 3 24 0 0 ppublish 4885975

1969 JAMA